Monitoring of minimal residual disease in acute myeloid leukemia
Open Access
- 30 November 2005
- journal article
- research article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 56 (2), 283-309
- https://doi.org/10.1016/j.critrevonc.2004.06.004
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemiaLeukemia, 2005
- Prognostic Implications of the Presence of FLT3 Mutations in Patients with Acute Myeloid LeukemiaLeukemia & Lymphoma, 2003
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemiaBlood, 2002
- A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trialBritish Journal of Haematology, 1999
- Detection of minimal residual disease in acute leukemia by flow cytometryCytometry, 1999
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCRBritish Journal of Haematology, 1998
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996
- Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemiaAnnals of Hematology, 1995